Antimicrobial susceptibility determined by the E test, Löwenstein- Jensen proportion, and DNA sequencing methods among Mycobacterium tuberculosis isolates - Discrepancies, preliminary results

Memorias do Instituto Oswaldo Cruz

Volumn 99, Issue 1, 2004, Pages 107-110

  Freixo, Maria Inês Moura ^a,b   Caldas, Paulo C S ^a,c   Said, Abbadi ^a,d   Martins, Fátima ^a,c   Brito, Rossana Coimbra ^a,e   De Fonseca, Leila Souza ^a,b   Saad, Maria Helena Féres ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c MINISTÉRIO DA SAÚDE   (Brazil)

^d Suez Canal University Faculty of Medicine   (Egypt)

^e HOSPITAL UNIVERSITÁRIO PEDRO ERNESTO   (Brazil)

Author keywords

DNA sequencing; E test; Mycobacterium tuberculosis; Susceptibility test

Indexed keywords

ANTIINFECTIVE AGENT; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ADHERENCE; BACTERIUM ISOLATE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA SEQUENCE; GENE MUTATION; GENOMICS; GENOTYPE PHENOTYPE CORRELATION; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPIC PLASTICITY; REPRODUCIBILITY; SEQUENCE ANALYSIS; STRAIN DIFFERENCE; VALIDATION PROCESS; WILD TYPE;

BACTERIA (MICROORGANISMS); MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 1642567345     PISSN: 00740276     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0074-02762004000100019     Document Type: Article

References (18)

1. Abbadi S, Rasheed HG, Morlock GP, Woodley CL, El Shanawy O, Cooksey RC 2001. Characterization of IS6110 restriction fragment length polymorphisms patterns and mechanisms of antimicrobial resistance for multitidrug-resistant isolates of Mycobacterium tuberculosis from a major reference hospital in Assiut, Egypt. J Clin Microbiol 39: 2330-2334.
2. Bártfai Z, Somoskövi A, Ködmön C, Zabó N, Puskás E, Kosztolányi L, Faragó E, Mester J, Parsons LM, Salfinger M 2001. Molecular characterization of rifampicin-resistant isolates of Mycobacterium tuberculosis from Hungary by DNA sequencing and line probe assay. J Clin Microbiol 39: 3736-3739.
3. Canetti G, Rist N, Grosset J 1963. Mesure de la sensibilité du baculle tuberculeux aux drogues antibacullaires par la méthode des proportions. Methodologie, critères de résistance, résultats, interprétation. Rev Tuberculose Pneumol 27: 217-272.
4. Cohn DL, Bustreo F, Raviglione MC 1997. Drug-resistant tuberculosis: review of the worldwide situation and the WHO/ IUATLD global surveillance project. Clin Infect Dis 24: S121-130.
5. Cooksey RC, Morlock GP, Glickman S, Crawford JT 1997. Evaluation of a line probe assay kit for characterization of rpoB mutations in rifampin-resistant Mycobacterium tuberculosis isolates from New York City. J Clin Microbiol 35: 1281-1283.
6. Cooksey RC, Morlock GP, McQueen A, Glickman SE, Crawford JT 1996. Characterization of streptomycin resistance mechanisms among Mycobacterium tuberculosis isolates from patients in New York City. Antimicrob Agents Chemother 40: 1186-1188.
7. Dobner P, Rusch-Gerdes S, Bretzel G, Feldmann K, Rifai M, Loscher T, Rinder 1997. Usefulness of Mycobacterium tuberculosis genomic mutations in the genes katG and inhA for the prediction of isoniazid resistance. Int J Tuberc Lung Dis 1: 365-369.
8. Hazbón MH, Orozco M del S, Labrada LA, Tovar R, Weigle KA, Wangler A 2000. Evaluation for susceptibility testing of multidrug resistant isolates of Mycobacterium tuberculosis. J Clin Microbiol 38: 4599-4603.
9. Honore N, Cole ST 1994. Streptomycin resistance in mycobac-teria. Antimicrob Agents Chemother 38: 328-242.
10. Meier A, Sander P, Schaper KJ, Scholz M, Böttger EC 1996. Correlation of molecular resistance mechanisms and phenotypic resistance levels in streptomycin-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother 40: 2452-2454.
11. Miller LP, Crawford JT, Shinnick TM 1994. The rpoB gene of Mycobacterium tuberculosis. Antimicrob Agents Chemother 35: 805-811.
12. NCCLS-National Committee for Clinical Laboratory Standards 1994. Antimycobacterial. susceptibility testing for Mycobacterium tuberculosis. Tentative standard M24-T, Villa Nova, PA.
13. Pablos-Méndez, A., Raviglione MC, Laszlo A, Binkin N, Rieder HL, Bustreo F, Cohn DL, Lambregts-van Weezenbeek CSB, Kim SJ, Chaulet P, Nunn P 1998. Global surveillance for anti-tuberculosis drug resistance, 1994-1997. N Engl J Med 338: 1641-1649.
14. Plikaytis BB, Gelber RH, Shinnick TM 1990. Rapid and sensitive detection of Mycobacterium leprae using a nested-primer gene amplification assay. J Clin Microbiol 28: 1913-1917.
15. Ramswamy S, Musser JM 1998. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tubercle and Lung Dis 79: 3-29.
16. Spindola de Miranda S, Kritski A, Filliol I, Mabilat C, Panteix G, Drouet E 2001. Mutations in rpoB gene of rifampicin-resistant Mycobacterium tuberculosis strains isolated in Brazil and France. Mem Inst Oswaldo Cruz 96: 247-250.
17. Telenti A, Imboden P, Marchesi F, Lowrie D, Cole S, Colston MJ, Matter L, Schopfer K, Bodmer T 1993. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 341: 647-650.
18. Wangler A, Mills K 1996. Testing Mycobacterium tuberculosis susceptibility to ethambutol, isoniazid, rifampin, and streptomycin by using E test. J Clin Microbiol 364: 1672-1676.